Literature DB >> 27394022

Herpes Zoster.

Kenneth Schmader1.   

Abstract

Herpes zoster causes significant suffering owing to acute and chronic pain or postherpetic neuralgia (PHN). Varicella-zoster virus-induced neuronal destruction and inflammation causes the principal problems of pain, interference with activities of daily living, and reduced quality of life in older adults. The optimal treatment of herpes zoster requires early antiviral therapy and careful pain management. For patients who have PHN, evidence-based pharmacotherapy using topical lidocaine patch, gabapentin, pregabalin, tricyclic antidepressants, or opiates can reduce pain burden. The live attenuated zoster vaccine is effective in reducing pain burden and preventing herpes zoster and PHN in older adults.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aged; Elderly; Herpes zoster; Postherpetic neuralgia; Varicella-zoster virus

Mesh:

Substances:

Year:  2016        PMID: 27394022     DOI: 10.1016/j.cger.2016.02.011

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  14 in total

Review 1.  The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.

Authors:  Cornelia M Weyand; Gerald J Berry; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

2.  A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine.

Authors:  W Katherine Yih; Martin Kulldorff; Inna Dashevsky; Judith C Maro
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

Review 3.  Herpes Zoster in the Older Adult.

Authors:  Amrita R John; David H Canaday
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

Review 4.  Modalities in managing postherpetic neuralgia.

Authors:  Meera Shrestha; Aijun Chen
Journal:  Korean J Pain       Date:  2018-10-01

5.  Association between Herpes Zoster and Osteoporosis: A Nested Case-Control Study Using a National Sample Cohort.

Authors:  Chanyang Min; Woo Jin Bang; Dong Jun Oh; Songyong Sim; Hyo Geun Choi
Journal:  Biomed Res Int       Date:  2019-07-30       Impact factor: 3.411

6.  Case Report Of Cryoneurolysis For The Treatment Of Refractory Intercostobrachial Neuralgia With Postherpetic Neuralgia.

Authors:  Garret Weber; Kenneth Saad; Motaz Awad; Tiffany H Wong
Journal:  Local Reg Anesth       Date:  2019-11-01

7.  An update of fire needle acupuncture for acute herpes zoster and prevention of postherpetic neuralgia in adults: A protocol for systematic review and meta-analysis.

Authors:  Jiaxuan Wang; Xindong Wang; Hongyan Xia; Na Zhang; Shiyu Lin; Jingchun Zeng; Guohua Lin
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

8.  Efficacy and safety of bloodletting for herpes zoster: A protocol for systematic review and meta-analysis.

Authors:  Xiaoyan Wang; Shaolei Huang; Guoliang Shao; Jian Zhang; Suyao Wang; Yanfei Lv; Feng Dong; Jing Han; Dianhui Yang
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 9.  Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Mario Boccadoro; Philippe Moreau; Jesus San-Miguel; Michele Cavo; Charlotte Pawlyn; Sonja Zweegman; Thierry Facon; Christoph Driessen; Roman Hajek; Melitios A Dimopoulos; Francesca Gay; Hervé Avet-Loiseau; Evangelos Terpos; Niklas Zojer; Mohamad Mohty; Maria-Victoria Mateos; Hermann Einsele; Michel Delforge; Jo Caers; Katja Weisel; Graham Jackson; Laurent Garderet; Monika Engelhardt; Niels van de Donk; Xavier Leleu; Hartmut Goldschmidt; Meral Beksac; Inger Nijhof; Niels Abildgaard; Sara Bringhen; Pieter Sonneveld
Journal:  Leukemia       Date:  2020-08-19       Impact factor: 11.528

10.  Herpes zoster and the subsequent risk of prostate cancer in an Asian population: A nationwide population-based cohort study.

Authors:  Yao-Hsuan Tsao; Chi-Jeng Hsieh; Yung-Shun Juan; Yung-Chin Lee; Jung-Tsung Shen; Hsun-Shuan Wang; Jhen-Hao Jhan; Jiun-Hung Geng
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.